PMID- 22293352 OWN - NLM STAT- MEDLINE DCOM- 20120702 LR - 20190720 IS - 1347-5215 (Electronic) IS - 0918-6158 (Linking) VI - 35 IP - 2 DP - 2012 TI - Natural vanadium-containing Jeju groundwater inhibits immunoglobulin E-mediated anaphylactic reaction and suppresses eicosanoid generation and degranulation in bone marrow derived-mast cells. PG - 216-22 AB - The high-affinity receptor for immunoglobulin E (IgE) (FcepsilonRI)-mediated activation of mast cells plays an important role in various allergic diseases. To assess the anti-allergic activity of natural vanadium-containing Jeju groundwater (JW), an in vivo passive cutaneous anaphylaxis (PCA) animal model and in vitro mouse bone marrow-derived mast cells (BMMCs) was used. JW inhibited cyclooxygenase-2 (COX-2)-dependent prostaglandin D(2) (PGD(2)) generation in a dose-dependent manner, with a concomitant reduction of COX-2 protein expression in IgE-induced BMMCs. In addition, JW inhibited 5-lipoxygenase (5-LOX)-dependent generation of leukotriene C(4) (LTC(4)) as well as degranulation in a dose-dependent manner. These results demonstrate that JW has dual COX-2/5-LOX inhibitory activity. In addition, vanadium pentoxide (V(2)O(5)), which is the major vanadium component of JW, also inhibited PGD(2) and LTC(4) generation as well as degranulation in IgE-induced BMMCs. Furthermore, oral administration of JW dose-dependently inhibited mast cell-dependent passive anaphylactic reaction in IgE-sensitized mice. Taken together, these results suggest that JW may be useful in regulating mast cell-mediated allergic response through the suppression of eicosanoid generation and degranulation in mast cells. FAU - Li, Xian AU - Li X AD - College of Pharmacy, Yeungnam University, Gyeongsan, Republic of Korea. FAU - Lu, Yue AU - Lu Y FAU - Yang, Ju Hye AU - Yang JH FAU - Jin, Ye AU - Jin Y FAU - Hwang, Seung-Lark AU - Hwang SL FAU - Chang, Hyeun Wook AU - Chang HW LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Japan TA - Biol Pharm Bull JT - Biological & pharmaceutical bulletin JID - 9311984 RN - 0 (Anti-Allergic Agents) RN - 0 (Water Pollutants, Chemical) RN - 00J9J9XKDE (Vanadium) RN - 2CU6TT9V48 (Leukotriene C4) RN - 37341-29-0 (Immunoglobulin E) RN - RXY07S6CZ2 (Prostaglandin D2) RN - SY7Q814VUP (Calcium) SB - IM MH - Anaphylaxis/drug therapy/immunology MH - Animals MH - Anti-Allergic Agents/*pharmacology MH - Bone Marrow Cells/cytology MH - Calcium/immunology MH - Cell Degranulation/drug effects MH - *Groundwater MH - Immunoglobulin E/immunology MH - Leukotriene C4/immunology MH - Male MH - Mast Cells/*drug effects/immunology MH - Mice MH - Mice, Inbred BALB C MH - Mice, Inbred ICR MH - Prostaglandin D2/immunology MH - Vanadium/*pharmacology MH - Water Pollutants, Chemical/*pharmacology EDAT- 2012/02/02 06:00 MHDA- 2012/07/03 06:00 CRDT- 2012/02/02 06:00 PHST- 2012/02/02 06:00 [entrez] PHST- 2012/02/02 06:00 [pubmed] PHST- 2012/07/03 06:00 [medline] AID - JST.JSTAGE/bpb/35.216 [pii] AID - 10.1248/bpb.35.216 [doi] PST - ppublish SO - Biol Pharm Bull. 2012;35(2):216-22. doi: 10.1248/bpb.35.216.